Czechia· CZ-0282929
NILOTINIB TEVA
A nilotinib product containing nilotinib hydrochloride dihydrate, registered in Czechia by Teva GmbH, Ulm. The same ATC class is registered in 14 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Nilotinib is registered in 14 of 19 countries.
Countries holding a registration under ATC L01EA03 (nilotinib), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 8 of them publish a price we can compare per daily dose
Nilotinib · ATC L01EA03
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of nilotinib costs, country by country.
Normalised to the WHO defined daily dose (0.6 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Nilotinib · price per daily dose (0.6 g)
USD · FX 28 Sept 2026
- CH Switzerland$56.31
The record
At a glance
SÚKL (Czech Republic)- Active substance
- NILOTINIB HYDROCHLORIDE DIHYDRATE
- Manufacturer
- Teva GmbH, Ulm
- Country
- Czechia (CZ)
- ATC code
- L01EA03
- ATC class
- Nilotinib
- Defined daily dose
- 0.6 g, O
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
756 interactions on record for nilotinib.
Graded by severity as the source publishes them — 303 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Nilotinib · interactions on record
756 records
- 303 severe
- 433 moderate
- 20 minor
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- OndansetronA04AA01severe
- GranisetronA04AA02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Nilotinib in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesnilotinibTorrent Pharmaceuticals Limited
- BelgiumNilotinib Accord 150 mgAccord Healthcare
- SpainNILOTINIB ACCORD 150 MG CAPSULAS DURAS EFGAccord Healthcare S.L.U.
- FranceNILOTINIB ACCORD 150 mg, géluleACCORD HEALTHCARE (ESPAGNE)
- NetherlandsNilotinib Accord 150 mg, harde capsulesAccord Healthcare S.L.U.
- SwedenNilotinib Accord 150 mg Kapsel, hårdAccord Healthcare S.L.U.
- PolandNilotinib AccordAccord Healthcare S.L.U.
- IcelandNilotinib AccordAccord Healthcare S.L.U.
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Nilotinib Stada, Nilotinib Teva
- Belgium · Nilotinb Eg, Nilotinib
- Bulgaria · Нилотиниб Зентива, Нилотиниб Стада
- Cyprus · Nilotinib Bioars, Nilotinib Olpha
- Germany · Nilotinib Al, Nilotinib Al 150 Mg Hartkapseln Al
- Denmark · Nilotinib "olpha", Nilotinib Stada
- Estonia · Nilotinib Olpha, Nilotinib Stada
- Spain · Nilotinib Cipla, Nilotinib Eugia
- Finland · Nilotinib Stada, Nilotinib Zentiva
- France · Nilotinib Arrow, Nilotinib Biogaran
- United Kingdom (Northern Ireland) · Nilotinib Amarox, Nilotinib Teva Uk
- Greece · Lobynia, Nilotinib Anabiosis
- Croatia · Nilmat, Nilotinib Devatis
- Hungary · Krufton, Nilotinib
- Ireland · Nilotinib Clonmel
- Iceland · Nilotinib, Nilotinib Accord
- Italy · Nilotinib Cipla, Nilotinib Eg
- Liechtenstein · Nilotinib Accord, Tasigna
- Lithuania · Krufton, Nilotinib Olpha
- Luxembourg · Nilotinib Eg, Nilotinib Eugia
- Latvia · Krufton, Nilotinib Olpha
- Malta · Nilotinib Hydrochloride Dihydrate Clonmel, Nilotinib Olpha
- Netherlands · Nilotinib Cf, Nilotinib Cipla
- Norway · Nilotinib Accord, Nilotinib Cipla
- Poland · Nilotinib Stada, Nilotinib Viatris
- Portugal · Nilotinib Eugia, Nilotinib Generis
- Romania · Krufton, Nilotinib Cipla
- Sweden · Nilotinib Cipla, Nilotinib Devatis
- Slovenia · Nilmat, Nilotinib Stada
- Slovakia · Krufton, Nilotinib
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/953346eb-2935-4afc-b892-514264031dac GET /v1/drugs/953346eb-2935-4afc-b892-514264031dac?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "CPS DUR",
"source": "sukl",
"strength": "150MG",
"pack_size": "392X1(14X28X1) I",
"substance": "NILOTINIB HYDROCHLORIDE DIHYDRATE",
"cz_kod_sukl": "0282929",
"product_type": "CH",
"substance_codes": "23452",
"registration_state": "R",
"registration_number": "44/672/24-C"
}See everything about nilotinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.